Bloomios, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021
August 19, 2021 at 01:17 pm EDT
Share
Bloomios, Inc. announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced sales was USD 2.456 million compared to USD 73,615 a year ago. Operating income was USD 212,938 compared to operating loss of USD 182,986 a year ago. Net income was USD 432,298 compared to net loss of USD 182,986 a year ago. Basic earnings per share from continuing operations was USD 0.03 compared to basic loss per share from continuing operations of USD 0.01 a year ago. Diluted earnings per share from continuing operations was USD 0.02 compared to diluted loss per share from continuing operations of USD 0.01 a year ago. For the half year, sales was USD 4.618 million compared to USD 73,615 a year ago. Operating income was USD 167,134 compared to operating loss of USD 288,702 a year ago. Net loss was USD 1.136 million compared to USD 288,702 a year ago. Basic loss per share from continuing operations was USD 0.09 compared to USD 0.02 a year ago.
Bloomios, Inc. manufactures, markets, and distributes hemp-derived supplements and cosmetic products through wholesale distribution channels in the United States, through its wholly owned subsidiary, Bloomios Private Label (BPL). BPL is engaged in the manufacturing, processing, sourcing and distribution of hemp-derived, nootropic and nutraceutical products to wholesalers and retailers. The Company manufactures hemp infused products ranging from human edibles, pet edibles, liquid consumables such as tinctures and shots, topicals, and smokable hemp. It provides support at each step from custom formulation, order fulfillment, and brand development. Its product categories include edibles, tinctures, oils, salves, capsules, balms, lotions, creams, beverages and pet treats. It offers its private-label and white-label customers a collections of customizable hemp products that includes over 80 products across seven categories in addition to custom formulation and manufacturing services.
BLOOMIOS, INC. 
